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Themechanisms of astrovirus pathogenesis are largely unknown, in part due to a lack of a small-animal model of disease. Using
shotgun sequencing and a custom analysis pipeline, we identified two novel astroviruses capable of infecting research mice, mu-
rine astrovirus (MuAstV) STL1 and STL2. Subsequent analysis revealed the presence of at least two additional viruses (MuAstV
STL3 and STL4), suggestive of a diverse population of murine astroviruses in research mice. Complete genomic characterization
and subsequent phylogenetic analysis showed that MuAstV STL1 to STL4 are members of the mamastrovirus genus and are
likely members of a newmamastrovirus genogroup. Using Rag1/mice deficient in B and T cells, we demonstrate that adaptive
immunity is required to control MuAstV infection. Furthermore, using Stat1/mice deficient in innate signaling, we demon-
strate a role for the innate immune response in the control of MuAstV replication. Our results demonstrate that MuAstV STL
permits the study of the mechanisms of astrovirus infection and host-pathogen interactions in a genetically manipulable small-
animal model. Finally, we detectedMuAstV in commercially available mice, suggesting that these viruses may be present in aca-
demic and commercial research mouse facilities, with possible implications for interpretation of data generated in current
mouse models of disease.
Recent studies in mouse models have highlighted complex in-teractions between viruses, genetic susceptibility, and disease
(reviewed in reference 59). To characterize the enteric virome of
specific-pathogen-free (SPF)-housed research mice in an unbi-
ased manner, we used shotgun sequencing, which revealed the
presence of multiple novel astroviruses. Astroviruses are nonen-
veloped, positive-sense, polyadenylated RNA viruses often associ-
ated with gastrointestinal (GI) disease (11, 44). Human astrovirus
1 (HAstV1) toHAstV8 are an important cause of gastroenteritis in
pediatric inpatients and outpatients, HIV-infected and immuno-
compromised populations, and the elderly (9, 10, 12, 16, 21, 22,
24, 28, 39, 44, 48, 53, 63). In addition, human astroviruses have
been associated with sporadic outbreaks of gastroenteritis in im-
munocompetent adults (4, 44, 47). As a viral agent of pediatric
gastroenteritis, HAstV is reportedly second only to rotavirus (12,
44), with a seroprevalence of neutralizing antibodies to HAstV1
nearing 90% by the age of 9 (35). To date, astroviruses have been
isolated from a number of hosts, including wild and domestic
animals, marinemammals, and birds, and new astrovirus-suscep-
tible hosts continue to be identified (11, 34, 42, 49, 52).
Astrovirus-related disease is not limited only to the GI tract.
Astroviruses are implicated as the cause of hepatitis in ducks and
encephalomyelitis in minks (5, 18, 20). In humans, an astrovirus
was identified in the central nervous system of an immunocom-
promised child with X-linked agammaglobulinemia who died of
encephalitis (51). Furthermore, we previously reported the pres-
ence of human astrovirus MLB2 in the plasma of a febrile child
(27).Despite the prevalence of human astrovirus infection and the
potential for extraintestinal disease, there are no specific treat-
ment protocols for astrovirus infection, and no vaccine exists. In
addition, little is known about the molecular mechanisms of as-
trovirus infection, replication, disease pathogenesis, or immunity.
The family Astroviridae is divided into the mamastrovirus and
avastrovirus genera, which are characterized by the ability to infect
mammals and avian species, respectively (44). Themamastrovirus
genus is further subdivided into two genogroups based on the
complete amino acid sequence of open reading frame 2 (ORF2)
and distinguishes genogroups I and II based on amean amino acid
genetic distance (p-dist) of 0.671  0.016 between the groups,
with intragenogroup distances ranging from 0.338 to 0.783 (31).
Across bothmamastrovirus and avastrovirus genera, the astro-
virus genome ranges from6.1 to 7.7 kb in length, not including the
3= polyadenylated tail, and contains threeORFs as well as 5= and 3=
untranslated regions (UTRs) (44). ORF1a encodes a polypeptide
of 920 to 935 amino acids (aa) containing several conserved mo-
tifs, including a serine protease (11, 44). A highly conserved hep-
tanucleotide motif and downstream hairpin structure at the
ORF1a-ORF1b junction generates a1 frameshift, leading to the
translation of anORF1a-ORF1bpolypeptidewhich is later cleaved
into polypeptides corresponding to ORF1a and ORF1b (11, 29,
41, 44).ORF1b encodes a polypeptide of approximately 515 to 528
aa, containing the RNA-dependent RNA polymerase (RdRP) (40,
44).ORF2 encodes a polypeptide consisting of 672 to 816 aawhich
contains the viral capsid (11, 40, 44).
Human case studies have highlighted the importance of the
adaptive immune system in the control of mamastrovirus disease
(51, 63). The turkey model of avastrovirus pathogenesis has been
used to characterize astrovirus disease and immune response (32,
33) but lacks the ability to easily dissect host determinants of as-
trovirus infection and immunology. Furthermore, while mamas-
trovirus tissue culture systems do exist (23, 38), the ability to elu-
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cidate molecular mechanisms that control mamastrovirus
infection and pathogenesis has been hampered by a lack of a
small-animal model.
In this paper, we report the first complete genome sequences of
astroviruses in research mice, murine astrovirus (MuAstV) STL1
and STL2. Subsequent analysis revealed the presence of at least
two additional MuAstV STL viruses, suggestive of a diverse pop-
ulation of related astroviruses. Phylogenetic analysis of ORF2 in-
dicated that the MuAstV STL viruses group with several other
newly described astroviruses in a genetic cluster distinct fromma-
mastrovirus genogroups I and II. MuAstV STL is capable of in-
fecting laboratory mice, which represent a genetically manipula-
ble small-animal model in which to study astrovirus infection.
Initial experiments using this model of mamastrovirus infection
revealed a role for both innate and adaptive immunity in the con-
trol of astrovirus replication. Finally, we show that MuAstV is
present in commercially available mice, with potential implica-
tions for existing disease models.
MATERIALS AND METHODS
Nucleic acid preparation and 454 sequencing. Shotgun sequencing was
performed as follows: stool samples were collected from C57BL/6J mice
and resuspended in 6 volumes of phosphate-buffered saline (PBS) (14).
The sample was centrifuged to pellet particulate matter, and the superna-
tant fluids were then passed through a 0.45-m-pore-size filter. Total
nucleic acid was isolated from 200 l primary stool filtrate using an
Ampliprep DNA extraction machine (Roche) according to the manu-
facturer’s instructions. To enable subsequent detection of both RNA and
DNA viruses, total nucleic acid from each sample was reverse transcribed
and amplified as previously described (61). Briefly, RNA templates were
reverse transcribed using primerA containing a 16-nucleotide (nt) spe-
cific sequence followed by 9 randomnucleotides for randompriming. The
16-nt specific sequence is unique for each sample and served as a barcode
in assigning sequencing reads to a sample. Sequenase (United States Bio-
chemical) was used for second-strand cDNA synthesis and for random-
primed amplification of DNA templates using PrimerA. Each sample was
then subjected to 40 cycles of PCR amplification using PrimerB contain-
ing the same 16-nt specific sequence as in the corresponding PrimerA.
Amplification products were pooled, adaptor ligated, and sequenced on
the 454 GS-FLX Titanium platform (454 Life Sciences).
Detection and analysis of viral sequences using VirusHunter soft-
ware. Sequences were analyzed using VirusHunter, a customized pipe-
line, as described previously (64). Briefly, sequence reads were assigned to
samples based on the unique barcode sequences (i.e., PrimerB sequences).
For further analysis, primer sequences were trimmed off and the sequence
reads were clustered using CD-HIT (43) to identify redundant reads. Se-
quences were clustered on the basis of 95% identity over 95% sequence
length, and the longest sequence from each cluster was picked as the
representative sequence. Then, sequences were masked by RepeatMasker
(http://www.repeatmasker.org). If a sequence did not contain a stretch of
at least 50 consecutive non-“N” nucleotides or if greater than 40% of the
total length of the sequence was masked, it was removed from further
analysis (i.e., “filtered”). Good-quality sequences after filtering were se-
quentially compared against (i) the human genome using BLASTn; (ii)
the GenBank nt database using BLASTn; or (iii) the GenBank nr database
using BLASTx (2). Minimal e-value cutoffs of 1e10 and 1e5 were ap-
plied for BLASTn and BLASTx, respectively. Sequences were phylotyped
as human, mouse, fungal, bacterial, phage, viral, or other based on the
identity of the top BLAST hit. Sequences without any significant hit to any
of the databases were placed in the “unassigned” category. If a sequence
aligned to both a virus and a member of another kingdom (e.g., a bacte-
riumor fungus)with the same e value, it was classified as “ambiguous.”All
eukaryotic viral sequences were further classified into viral families based
on the taxonomy identification of the best hit.
All viral sequences and unassigned sequences from each sample were
assembled into contigs using Newbler (454 Life Sciences) with default
parameters. If a sample was sequenced multiple times, all available se-
quencing data were used to try to obtain the best assembly.
Genome amplification and confirmatory sequencing. Total RNA
was extracted from the murine stool samples previously used for shotgun
sequencing with an RNeasy minikit (Qiagen, Valencia, CA) to generate
complete genomic sequences. To generate partial genome sequences cor-
responding to ORF2, total RNAwas extracted frommurine stool samples
harvested from immunocompetentmice housed in different SPF facilities
at Washington University. One microgram of RNA was used as the tem-
plate for rapid amplification of cDNA ends (RACE) reactions to generate
the 5= and 3= genome ends with 5= RACE and 3= RACE kits (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. To generate
full genomic sequences, one microgram of RNA was used as the template
for cDNA synthesis using a SuperScript III first-strand synthesis kit and an
oligo(dT)12–20 primer (Invitrogen) according to the manufacturer’s in-
structions. Sequences were then amplified using Elongase enzyme mix
(Invitrogen) and primers 5=-CCAAGAAAGAGGCACTAGTGGCACT
C-3= and 5=-GTTTTTTTTTTTTTTTTTTTTTGCCAATTTTTATGCCA
ATTATATCACCC-3=. Partial genome sequences corresponding to ORF2
were amplified using a 3=RACE kit and gene-specific primer 5=-CTTTGG
AGGGGHGGACCAA-3=. The resulting PCR products were gel purified
and ligated into a pCR4-TOPO TA sequencing vector (Invitrogen). Uni-
versal M13 forward and reverse primers were used for sequencing, and
primer walking was applied as needed. Four clones were used to construct
consensus sequence MuAstV STL1 with 2-to-4-fold redundancy using
Geneious Pro v5.0.4. Three clones were used to construct the MuAstV
STL2 consensus sequence with 2-to-4-fold redundancy. MuAstV STL3
and STL4 consensus sequences were each generated from three clones
with 2-to-4-fold redundancy. Predicted ORFs were identified using
Geneious. All protein motifs were predicted using Pfam (17).
Phylogenetic analysis. Sequences from astrovirus genomic segments
encoding ORF1a, -1b, and -2, available in GenBank as of 26 July 2012,
were translated. These sequences were aligned using ClustalX 2.0.12 (37).
Phylogenetic inference was performed with maximum parsimony using
PAUP 4b10 (57) and maximum likelihood using RAxML (55) and a
BLOSUM62 transitionmatrix with 1,000 bootstrap replicates. The result-
ing phylogenetic trees were visualized using FigTree 1.3.1 (http://tree.bio
.ed.ac.uk/software/figtree). MEGA 5.05 was used for distance estimation
(uncorrected p-dist) (58).
Mice. C57BL/6J, B6.Rag1/ (45), and Stat1/ (13) mice were bred
and housed in an enhanced-barrier SPF facility atWashington University
in St. Louis in compliance with federal and institutional guidelines (8).
B6.Rag1/mice were also purchased from The Jackson Laboratory (Bar
Harbor, ME). All studies were performed using age-matched female mice
between 8 and 12 weeks of age.
For MuAstV STL detection in commercially available mice,
B6.Rag1/mice (B6.129S7-Rag1tm1Mom/J; catalog no. 002216) (45) were
ordered from The Jackson Laboratory facility AX30, Rag2/ mice
(129S6/SvEvTac-Rag2tm1Fwa; catalog no. RAG2-F) (54) were ordered
from Taconic facility IBU25, and Fox Chase SCID mice (CB17/
Icr-Prkdcscid/IcrCrl; catalog no. 236) (6) were ordered from Charles River
facility W09. Upon arrival, mice were maintained in their commercial
transport container until they were sacrificed for sample collection on the
same day.
Measurement of viral RNA by TaqMan qPCR. Total RNA was ex-
tracted from individual stool pellets using an RNeasy minikit (Qiagen) or
from tissue samples using TRIzol reagent (Invitrogen). One-tenth of the
total stool RNA or 1 g of tissue RNA was reverse transcribed using
ImpromII reverse transcriptase (RT) (Promega, Madison, WI) and ran-
dom primers (Invitrogen) to yield cDNA. Triplicate quantitative PCRs
(qPCR) were performed using 1/10 of the cDNA, primers specific to an
80-nt region of ORF1b (sense, 5=-TACATCGAGCGGGTGGTCGC-3=;
antisense, 5=-GTGTCACTAACGCGCACCTTTTCA-3=), and a TaqMan
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probe (Applied Biosystems, Foster City, CA) with the sequence 5=-TTTG
GCATGTGGGTTAA-3= containing a 5= 6-carboxyfluorescein (FAM) dye
label, 3= nonfluorescent quencher (NFQ), and minor groove binder
(MGB). The number of genome copies per sample was determined by
comparison to a standard curve (generated by a 10-fold dilution of target-
containing plasmid in yeast tRNA [Invitrogen]). For stool samples, the
number of genome copies per samplewasmultiplied by 100 to account for
dilution from total RNA originally extracted from the stool pellet and is
reported as the number of genome copies per stool pellet.
Nucleotide sequence accession numbers.The sequences forMuAstV
STL1, STL2, STL3, and STL4 have been deposited in GenBank and have
been assigned accession numbers JX544743 to JX544746.
RESULTS
Detection of novel astroviruses using shotgun sequencing. To
examine the mouse virome in an unbiased manner, we generated
fecal RNAandDNA libraries from three immunocompetentwild-
type mice, shotgun sequenced them, and used VirusHunter (14–
16, 25, 26, 50, 64) to analyze the resulting reads.We identified 132
sequences (76, 21, and 35 from mice A, B, and C, respectively)
with significant similarity to known astrovirus sequences. No
other viral reads were identified. The viral reads, as well as reads
with no detectable homology to sequences in public databases,
detected in the feces of mouse A were used to assemble a 6,748-
nucleotide (nt) contig with 9-fold coverage. A BLASTx (2) search
of the NCBI nr database identified this contig to be a highly diver-
gent astrovirus with at most 60% identity to a 205-aa region of the
most closely related virus, HAstV-6 isolate Katano (Fig. 1A). As-
sembly of reads from the feces of mouse B generated three contigs
ranging from 1,024 to 2,463 nt with 89.1% to 95.2% identity to
mouse A contig 1 (Fig. 1B). Assembly of reads detected in the feces
of mouse C generated four contigs ranging from 288 to 3,095 nt
with 99.0% to 99.7% nt identity to the 6,748-nt contig from
mouseA (data not shown). These data suggested the presence of at
least two novel astroviruses in our research mouse facility.
Generation and sequencing of complete and partial murine
astrovirus genomes. Subsequent analysis of the fecal specimens
from mouse A and mouse B utilizing RACE reactions and tradi-
tional Sanger sequencing generated the complete consensus ge-
nomes of the two mouse astroviruses MuAstV STL1 and STL2
(Fig. 2). Excluding the poly(A) tail, MuAstV STL1 and STL2 were
6,817 and 6,806 nt long, respectively, and shared 93.4%nt identity
across their genomes.
To begin to assessMuAstV diversity, we collected fecal samples
from two nonobese diabetic mice, housed in two different re-
searchmouse facilities atWashington University. A primer corre-
sponding to the highly conserved region upstream of ORF2 was
used in a 3=RACE reaction to generateORF2 consensus sequences
from these samples, here calledMuAstV STL3 and STL4.MuAstV
STL3 and STL4 showed 95.3%nt identity to each other and 89.6%
to 91.4% nt identity to MuAstV STL1 and STL2. These data dem-
onstrate the presence of at least four novel astroviruses in research
mouse facilities at Washington University.
The genome organization of MuAstV STL is consistent with
those of other mamastroviruses. MuAstV STL1 and STL2 were
predicted to contain a 5=UTR, three ORFs (ORF1a, -1b, and -2), a
3=UTR, and a poly(A) tail. The 5=UTRwas determined to be 46 nt
in length. The 3= UTRs of MuAstV STL1 and STL2 were deter-
mined to be 90 and 91 nt in length, respectively. ORF1a was pre-
dicted to encode a 928 (MuAstV STL1)- or 924 (MuAstV
STL2)-aa protein, with each containing a trypsin-like peptidase
domain as revealed by Pfam analysis (17) and showing significant
similarity (minimal e-value cutoff of 1e5) to those of known
astroviruses by BLASTp (2). The differences in four amino acids
occurred downstream of the putative protease motif. The 58-nt
ORF1a-ORF1b junction ofMuAstV STL1 and STL2 contained the
heptanucleotide frameshift signal (AAAAAAC) conserved in all
astroviruses (11, 29, 41, 44). Furthermore, FSFinder analysis (46)
confirmed that the downstream sequence may form a stem-loop
structure required for a 1 ribosomal frameshift to lead to
ORF1a-ORF1b translation (7, 19, 44). The first amino acid in
frame with the frameshift signal was predicted to be the start po-
sition for ORF1b of MuAstV STL1 and STL2. ORF1b of MuAstV
STL1 and STL2 is predicted to encode a 502-aa protein containing
an RdRP domain, consistent with other members of the Astroviri-
dae family (11, 44).
MuAstV STL contained a sequence that is highly conserved
amongmammalian astroviruses upstream of ORF2, CUUUGGA
FIG 1 Identification of novel astrovirus sequences. (A) Comparison between the longest contig assembled from mouse A and HAstV6 isolate Katano
(HM237363), the most closely related virus. *, percent amino acid identity and length of the best aligned homologous region compared to the reference genome
sequence. (B) Comparison between the longest contig assembled frommouse A and contigs assembled frommouse B. **, percent nucleotide identity across the
indicated contig.
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passes the ORF2 start codon (in bold) and is suggested to be a
promoter for subgenomic RNA synthesis (44, 60). As in most
other mamastroviruses (11), MuAstV STL had an 8-nt region of
overlap at the end of ORF1b and beginning of ORF2, with ORF2
maintained in the same frame as ORF1a. ORF2 of MuAstV STL1
and STL2 was predicted to encode an 819-aa protein containing
the structural capsid protein. Collectively, these data demonstrate
that the genome organization of MuAstV STL1 and STL2 is con-
sistent with those of other members of the Astroviridae family and
of the mamastrovirus genus in particular.
MuAstV STL viruses aremembers of a putative newmamas-
trovirus genogroup. To evaluate the relationship between
MuAstV STL1 to STL4 and other known astroviruses, we per-
formed phylogenetic analysis using translated complete amino
acid sequences fromORF2 of 72mamastroviruses (Fig. 3). Phylo-
genetic analyses ofMuAstV STL1 and STL2 performed for ORF1a
and -1b showed similar relationships between these novel astro-
viruses and known astroviruses (data not shown). In all analyses,
the MuAstV STL viruses clustered with the mamastrovirus genus
and not the avastrovirus genus, demonstrating that the MuAstV
STL viruses are mamastroviruses.
The MuAstV STL viruses were most closely related to several
recently characterized porcine and wild boar astroviruses but
shared only 33% to 36% amino acid identity in the capsid region
and 63% to 67% amino acid identity in the RdRP region. This
clade also included an astrovirus sequence found in laboratory
mice in Cincinnati, OH, and recently uploaded to GenBank (mu-
rine astrovirus strain TF18LM) but was highly divergent from an
astrovirus sequence previously detected in a wild house mouse
(Mus musculus; mouse astrovirus M-52/USA/2008) (49), indicat-
ing that the potential population of murine astroviruses is quite
diverse.
In analyses of ORF2, the MuAstV STL viruses, along with por-
cine andwild boar astroviruses, formed a distinct cladewith p-dist
values of 0.762 0.010 and 0.789 0.010 with respect tomamas-
trovirus genogroups I and II, respectively. Intragroup p-dist val-
ues were 0.548  0.010, 0.629  0.011, and 0.641  0.009 for
mamastrovirus genogroups I and II and the MuAstV STL-con-
taining clade, respectively. These p-dist values suggested that the
MuAstV STL viruses may bemembers of a new genogroup within
the mamastrovirus genus.
Asensitive androbustqRT-PCRassay forMuAstVdetection.
As MuAstV STL1 and STL2 were originally identified in the
feces of asymptomatic wild-type mice, we examined whether
MuAstV STL was present in the feces of other mice from the
same SPF research mouse colony. To quantify the number of
MuAstV STL1 and STL2 genome copies in tissues and feces, we
designed a TaqMan-based quantitative reverse transcriptase
PCR (qRT-PCR) assay (Fig. 4A), which targeted a 72-bp region
of the RdRP conserved between MuAstV STL1 and STL2.
Across multiple experiments, the assay consistently detected
from 106 to 101 genome copies, and 1 genome copy was de-
tected in 2 of 3 technical replicates consistent with Poisson
distribution statistics, demonstrating that this assay was both
sensitive and robust.
Innate and adaptive immunity contribute to the control of
MuAstV replication. Given that previous human studies have
implicated the adaptive immune system as essential in the con-
trol of astrovirus pathogenesis (63), we measured the number
of astrovirus genome copies present in the feces of mice defi-
cient in B and T cells due to a mutation in Recombination
Activating Gene 1 (Rag1) (45). While these mice exhibited no
overt signs of illness, we detected up to 109 astrovirus genome
copies per fecal pellet. Notably, 21/21 Rag1/ mice that we
screened were positive for astrovirus (data not shown). These
data suggest that adaptive immunity is important for restrict-
ing MuAstV replication.
To assess the role of innate and adaptive immunity in restrict-
ing MuAstV replication, we examined the time course of natural
astrovirus infection in wild-type mice and mice deficient in signal
transducer and activator of transcription 1 (Stat1) (13). As previ-
ous studies have shown that astrovirus infections may spread be-
yond the GI tract (5, 51), we chose to examine infection of ex-
traintestinal tissues as well as intestinal infection and fecal
shedding. In order to ensure infection by the same viruses, we
cohoused wild-type and Stat1/ mice with infected Rag1/
mice for 14 days.
Consistent with our screening data from Rag1/ mice, we
observed high levels of MuAstV shedding in fecal samples from
FIG 2 Schematic of theMuAstV STL genome. Predicted open reading frames (ORFs) are represented by boxes and the 5= and 3=UTRs are represented by a black
line. The genome coordinates are noted at the top. Gray boxes depict predicted domains based on the corresponding amino acid sequence. The black arrowheads
indicate the conserved heptanucleotide frameshift motif (AAAAAAC). Human astrovirus 1 is depicted for comparison. PRO, trypsin-like peptidase domain; FS,
frameshift signal; POL, RdRP; A(A)n, 3= poly(A) tail; nt, nucleotides.
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FIG 3 MuAstV STL is a member of a putative third genogroup of mamastroviruses. Genomic sequences corresponding to ORF2 were translated and aligned.
Phylogenetic analyses were performed using maximum-parsimony (MP) and maximum-likelihood (ML) methods with 1,000 bootstrap replicates. The boot-
strap support (ML/MP) is indicated adjacent to each branch of the best-scoring ML tree where significant. Corresponding sequences from representative
avastroviruses were included for comparison. GenBank accession numbers immediately precede each sequence name.
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Rag1/ mice at day 0 and at all time points tested (Fig. 4B). In
contrast, low levels of MuAstV were observed in the feces of both
wild-type and Stat1/mice at day 0, prior to cohousing. After 2
days of cohousing, elevated levels of MuAstV genome copies were
detected in feces fromwild-type and Stat1/mice, with Stat1/
mice shedding significantly more MuAstV than wild-type mice at
day 2 (P  0.05). Overall, levels of MuAstV shedding over the
course of the experiment differed significantly by genotype (P 
0.0001 for two-way comparisons). These data suggest that both
the innate and adaptive immune systems contribute to the control
of MuAstV replication.
We next analyzed the tissue distribution of MuAstV STL after
14 days of cohousing.We detected high levels of genome copies in
the GI tract of Rag1/mice (Fig. 4C), consistent with our obser-
vation that Rag1/mice shed up to 109 genome copies per stool
pellet. The quantity of viral genome copies detected in the GI tract
of wild-type and Stat1/mice was significantly lower than in the
Rag1/mice (P 0.001 for all GI tract tissues tested). MuAstV
RNAwas detected in the liver and kidney ofRag1/mice but not
in the liver or kidney of wild-type or Stat1/ mice. While we
occasionally detected low levels of MuAstV RNA in the spleen of
Stat1/mice, we did not detect any genome copies in the spleen
of wild-type mice. We were unable to detect MuAstV STL in the
brain of any mouse tested. In aggregate, these data suggest a role
for both the innate and adaptive immune systems in the control of
astrovirus infection and replication.
MuAstV is present in mice purchased from commercial
mouse vendors. Since we had detected MuAstV STL in our re-
searchmouse facility, we assessed whetherMuAstVwas present in
mice purchased from commercial vendors. As we had observed
extremely high levels ofMuAstV STL in the feces ofRag1/mice,
we decided to assess the presence of MuAstV in commercially
availablemicewith adaptive immune deficiencies. Of the available
options from three commercial vendors, we purchased Rag1/
mice, Rag2/mice (54), and SCID mice (6).
Consistent with our previous findings in Rag1/ mice from
our academic researchmouse facility, we observed extremely high
levels of MuAstV in fecal and tissue samples from Rag1/ and
Rag2/mice from commercial mouse facilities (Fig. 5). While
we did detect a limited number of MuAstV genome copies in
the feces of two out of three SCID mice, none were detected in
tissue samples. These mice may have been truly negative for
MuAstV or may have been infected with a strain that we were
unable to detect using our MuAstV STL-specific primers and
probe. Overall, the presence of MuAstV in both academic and
commercial mouse facilities strongly suggests that MuAstV is a
FIG 4 Adaptive and innate immune responses contribute to the control of MuAstV infection. (A) Standard curve of MuAstV STL qRT-PCR targeting a
conserved region within the RdRP. Cycle threshold (CT) is plotted as a function of the quantity of input plasmid containing the target region. Data are
means  standard errors of the means determined for triplicate samples and are representative of the results of at least three experiments. (B and C)
Wild-type, Stat1/, and Rag1/mice were cohoused for 14 days. (B) Stool samples were collected every 2 days and analyzed for MuAstV STL genome
copy numbers by qRT-PCR. (C) At day 14, mice were sacrificed and the quantity of viral RNA in the indicated tissues was determined by qRT-PCR. Viral
RNA levels shown represent means  standard errors of the means determined for six mice pooled from two independent experiments. The dotted line
indicates the limit of detection for the assay. Statistical significance was analyzed by two-way analysis of variance (ANOVA) with a Bonferroni posttest
correction. *, P  0.05; **, P  0.001; ***, P  0.0001.
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common agent in laboratory mice, likely present in many re-
search mouse facilities.
DISCUSSION
We present here the complete genome sequence of two novel as-
troviruses,MuAstV STL1 and STL2, initially discovered in immu-
nocompetent mice housed in a specific-pathogen-free academic
mouse facility. MuAstV STL is a member of the mamastrovirus
genus and highly divergent from the previously described astrovi-
rus found in a wild housemouse (49). Analysis ofMuAstV natural
infection revealed a requirement for adaptive immunity in the
control of MuAstV replication and spread. The discovery and
complete genomic characterization ofMuAstV STL, an astrovirus
capable of infecting research mice, provide an opportunity to in-
vestigate biology and immunology of a mammalian astrovirus,
with implications for our understanding of human astrovirus dis-
ease mechanisms.
A new model of astrovirus infection. Turkey astrovirus 2
(TAstV2) has been used to study astrovirus pathogenesis in young
turkeys and has been the only small-animal model of astrovirus
infection and pathogenesis to date (33, 44). TAstV2, as a member
of the avastrovirus genus, is genetically distinct from the mamas-
troviruses, including human astroviruses. Here, we have shown
that the mamastrovirus MuAstV STL is capable of infecting re-
searchmice, an ideal system in which to examine astrovirus infec-
tion and host-virus interactions. Indeed, our initial studies during
the course of naturalMuAstV infection inmice demonstrated that
the adaptive immune system is essential in restricting murine as-
trovirus replication, as has been reported for human astrovirus
replication and persistence (51, 63). In addition, we also used this
new model to identify a role for Stat1 in controlling astrovirus
replication. Thus, this animal model is the first genetically manip-
ulable small-animalmodel with which themolecularmechanisms
of astrovirus infection may be elucidated.
MuAstV STL belongs to a potentially novel mamastrovirus
genogroup. Our phylogenetic analysis of the mamastroviruses,
including several recently described astroviruses, provides sup-
port for the addition of a third potential genogroup which com-
prises MuAstV STL as well as astroviruses that infect rats, pigs,
deer, and cattle but not (to date) humans. The significance of the
viruses within this putative new genogroup remains to be seen. At
least one strain within this new putative genogroup has been as-
sociated with diarrheal disease in its host (36), suggesting that
members of this proposed genogroup may have the potential to
exhibit signs of classical human astrovirus disease.
In addition to the putative genogroup III to which MuAstV
STL belongs, our analysis provides support for the creation of up
to three additional mamastrovirus genogroups. AstV MLB1 and
STL2, bottlenose dolphin astrovirus, and ovine astrovirus 2 and
porcine astrovirus 5 all have deep branches and p-dist values
greater than 0.671 with respect to the other genogroups. The cre-
ation of three new genogroups would serve to reduce the intrag-
enogroup p-dist values, which previously overlapped with the in-
tergenogroup values, likely due to the more limited number of
astrovirus sequences available for analysis at the time the current
taxonomy was established. The recent characterization of a num-
ber of novel astroviruses added resolution to our analysis of phy-
logenetic relationships and allowed us to detect a total of six po-
tential genogroups within the mamastrovirus genus.
Immune modulation of astrovirus infection. The mecha-
nisms by which the immune system responds to astrovirus infec-
tion are not well defined. A role for T- and B-cell-mediated im-
munity in controlling AstV infection is supported by case studies
describing chronic astrovirus infection in two T-cell-deficient
children and astrovirus-associated encephalitis in a child with X-
linked agammaglobulinemia (51, 63). Experiments using TAstV2
have demonstrated that antibodies are not essential to controlling
viral infection (32), but the importance of the humoral response
itself has not been examined formamastroviruses.UsingMuAstV,
we demonstrated that B and T cells are required to control astro-
virus replication inmultiple tissues as well as fecal shedding. Con-
sistent with observations in T-cell-deficient children, we detected
persistent astrovirus infection and shedding in the absence of B
and T cells. Further studies are needed to assess the importance of
each cell type in the modulation of astrovirus infection, but it is
clear that the adaptive immune system is required for control of
astrovirus replication.
While adaptive immunity plays a dominant role in the control
of MuAstV infection, our results also provide evidence for a role
for innate immunity. We observed increased MuAstV replication
and shedding in Stat1/mice compared to wild-typemice. Stat1
is required for type I and II interferon signaling, and Stat1/mice
are more susceptible to viral infection (13). Stat1 has also been
shown to be essential for the expression of inducible nitric oxide
synthase (iNOS) in intestinal epithelial cells (56), and nitric oxide
activity is induced in the intestines of TAstV2-infected turkey em-
bryos, thus suppressing astrovirus replication (32). It will be in-
teresting to assess the role of iNOS during the course of mamas-
trovirus replication as well.
Research implications of prevalent astrovirus infection. The
ability to interpret data generated in small-animal models of dis-
ease pathogenesis requires an accurate representation of the im-
mune response to perturbation. Subclinical infection may alter
immune phenotypes and baseline homeostasis (1, 3, 8). For exam-
ple, in the case ofmouse hepatitis virus (MHV) infection, inwhich
clinical signs of disease are not apparent in immunocompetent
adults, the inadvertent exposure of nonobese diabetic mice to
MHV led to a decrease in diabetes incidence (62). Due to the
potential for confounding experimental outcomes, homeostasis-
FIG 5 MuAstV detection in commercially available mice. Mice lacking B and
T cells were ordered from three vendors in the United States and immediately
sacrificed upon delivery. Viral genomes in (A) fecal samples or (B) mesenteric
lymph nodes were quantitated using a qRT-PCR. Viral RNA levels shown
represent means standard errors of the means of the results determined for
three mice. The dotted lines denote the limit of detection for each assay.
Yokoyama et al.
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altering agents such as MHV are generally excluded from SPF
facilities.
MuAstV was identified in mice purchased from several com-
mercial vendors in the United States as well as in mice in several
mouse research facilities at Washington University, suggesting
that it may be present inmany academic and commercial research
facilities. Indeed, the sequence of murine astrovirus strain
TF18LM isolated from a research facility in Cincinnati, OH, was
similar to that of MuAstV STL by phylogenetic analysis.
While MuAstV was found in asymptomatic mice, its effects on
host immunity and physiology are not known. Importantly, dif-
ferences in astrovirus presence between facilities, or even between
groups of experimental and control animals, may contribute to
altered outcomes. Our previous studies have demonstrated the
importance of the combination of genetic susceptibility and envi-
ronmental factors in disease phenotypes. In particular, we showed
that murine norovirus, which was originally discovered as a com-
mon contaminant in research mouse facilities, triggers Crohn’s
disease-like pathology in mice hypomorphic for the autophagy
protein Atg16L1 (8, 30). Standard methods for animal health
monitoring currently account only for known pathogens; how-
ever, our identification of multiple viruses in research mice sug-
gests that this approach does not detect all possible contributors to
disease phenotypes. An unbiased approach to animal healthmon-
itoringmight reveal additionalmembers of themouse virome and
contribute to the reliability and interpretation of data from the
animal models on which our understanding of disease mecha-
nisms so heavily relies.
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